Home / Diseases Index / Polyarteritis Nodosa
🩺 Clinical Pathology & Repertory Reference

Polyarteritis Nodosa

Comprehensive Diagnostic & Therapeutic Reference Profile

Also known as: PAN; Classic Polyarteritis Nodosa; Systemic Necrotizing Vasculitis

📖
Section 1

Disease Overview

Polyarteritis Nodosa (PAN) is a rare, systemic necrotizing vasculitis that primarily affects medium-sized muscular arteries. It leads to inflammation, tissue necrosis, and organ damage due to ischemia. Unlike ANCA-associated vasculitis, PAN does not involve capillaries, venules, or arterioles, sparing the lungs.

🏥
Section 2

Medical Classification

Disease Category
Rheumatological Disorders
ICD Classification
ICD-10: M30.0
🧬
Section 3

Etiology & Causes

The exact cause remains idiopathic in most cases. Approximately 10–30% of cases are associated with chronic Hepatitis B virus (HBV) infection, triggering an immune-complex mediated response. Genetic factors are less defined compared to other vasculitides.

⚙️
Section 4

Pathophysiology

PAN involves segmental inflammation of medium-sized arteries. Immune complex deposition in vessel walls triggers complement activation, neutrophil infiltration, and fibrinoid necrosis. This results in luminal narrowing, thrombosis, and the formation of characteristic microaneurysms, leading to distal ischemia and end-organ infarction.

📊
Section 5

Epidemiology

Annual incidence is 2–9 per million, typically occurring in adults aged 40–6


  1. It shows a slight male predominance (1.5:1 ratio).

⚠️
Section 6

Risk Factors

Chronic Hepatitis B infection, male gender, advanced age, and exposure to certain drugs (e.g., sulfonamides) are identified triggers.

🤒
Section 8

Symptoms

A. Early Symptoms: Unexplained weight loss, malaise, low-grade fever, myalgia, arthralgia.
B. Common Symptoms: Abdominal pain (post-prandial), skin nodules, livedo reticularis, hypertension.
C. Advanced Symptoms: Peripheral neuropathy (mononeuritis multiplex), digital gangrene, renal insufficiency.
D. Emergency Symptoms: Bowel perforation, myocardial infarction, intracranial hemorrhage, acute renal failure.

🩺
Section 9

Physical Examination

Hypertension is common due to renal artery involvement. Palpation may reveal tender subcutaneous nodules or ulcers. Neurological exams often show asymmetrical distal weakness (foot drop or wrist drop).

🔍
Section 10

Diagnostic Evaluation

A. Clinical Assessment: ACR/Chapel Hill criteria.
B. Laboratory Testing: Elevated ESR/CRP, anemia, HBV screening.
C. Imaging Studies: CT/MR angiography of mesenteric/renal arteries.
D. Functional Tests: EMG/NCS for nerve involvement.
E. Biopsy Findings: Fibrinoid necrosis of medium-sized arteries.
F. Genetic Testing: Not indicated.
G. Differential Diagnosis: ANCA-associated vasculitis, SLE, rheumatoid vasculitis.

🧪
Section 11

Laboratory Tests

Erythrocyte Sedimentation Rate (ESR)
Type: Blood Test
Purpose: Inflammatory marker
Expected Findings: Elevated
Interpretation: Non-specific indicator of systemic activity

📷
Section 12

Imaging Studies

Visceral Angiography: Identifies characteristic microaneurysms in renal, hepatic, or mesenteric arteries (Gold standard for diagnosis).

🔀
Section 13

Differential Diagnosis

Microscopic Polyangiitis (MPA) which involves lungs and glomerulonephritis (PAN spares both).

💢
Section 14

Complications

Renal failure, bowel infarction, stroke, secondary hypertension, and chronic neuropathy.

💊
Section 15

Treatment Options

A. Lifestyle Modifications: Smoking cessation, sodium reduction.
B. Preventive Measures: Vaccination for HBV.
C. Medical Treatment: Corticosteroids (Prednisone) and Cyclophosphamide (for severe cases).
D. Surgical Treatment: Rare, usually for bowel perforation or revascularization.
E. Interventional Procedures: Angioplasty for stenotic arteries.
F. Rehabilitation: Physical therapy for mononeuritis multiplex.
G. Emergency Management: High-dose pulse methylprednisolone.

📉
Section 16

Prognosis

Without treatment, the 5-year survival rate is <15%; with treatment (steroids/immunosuppressants), survival reaches 80-90%.

🛡️
Section 17

Prevention

Screening for HBV and avoiding unnecessary medications.

🌿
Section 19

Homeopathic Perspective

The following homeopathic remedies have been historically indicated for symptoms associated with Polyarteritis Nodosa. Selection should be based on individualized symptom totality and constitutional assessment.

📝 Clinical Notes:
Expert guide on Polyarteritis Nodosa (PAN), a systemic vasculitis. Learn about causes, diagnosis via angiography, and modern immunosuppressive treatments.
Section 20

FAQs

Q: What is Polyarteritis Nodosa?
Polyarteritis Nodosa (PAN) is a rare, systemic necrotizing vasculitis that primarily affects medium-sized muscular arteries. It leads to inflammation, tissue necrosis, and organ damage due to ischemia. Unlike ANCA-associated vasculitis, PAN does not involve capillaries, venules, or arterioles, spari...
Q: What are the main symptoms of Polyarteritis Nodosa?
A. Early Symptoms: Unexplained weight loss, malaise, low-grade fever, myalgia, arthralgia. B. Common Symptoms: Abdominal pain (post-prandial), skin nodules, livedo reticularis, hypertension. C. Advanced Symptoms: Peripheral neuropathy (mononeuritis multiplex), digital gangrene, renal insufficiency....
Q: What causes Polyarteritis Nodosa?
The exact cause remains idiopathic in most cases. Approximately 10–30% of cases are associated with chronic Hepatitis B virus (HBV) infection, triggering an immune-complex mediated response. Genetic factors are less defined compared to other vasculitides....
Q: Which homeopathic remedies are recommended for Polyarteritis Nodosa?
Based on clinical repertory references, recommended remedies include: Arnica, Sulphur, Nux Vomica, Belladonna, Lycopodium. Selection should be individualized based on the patient's complete symptom picture.
Q: When should I see a doctor for Polyarteritis Nodosa?
Consult a healthcare professional if you experience persistent or worsening symptoms, or if the condition significantly impacts your daily activities.
📚
Section 21

References

  • Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
  • Robin Murphy — Lotus Materia Medica (3rd Edition)
  • William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
  • ICD-10/ICD-11 Classification — World Health Organization
  • Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊
Section 22

Clinical Calculator

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Polyarteritis Nodosa.

🔬 Advanced Lab Blood Report Analyzer

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.

📄 Drag & Drop bloodwork PDF here or click to select file
— OR —
Upload a PDF or paste report text to generate clinical pathology interpretations.

📊 Pathology Calculators

Browse our full library of 200+ medical and pathology calculators.

📊 Browse All Calculators

Clinical Specifications

Reference ID CPD-90268
Disease Group Rheumatological Disorders
Content Sections 20 Active Sections

Clinical Consultation

Speak with our specialists for a customized treatment protocol for this condition.

📅 Request Consultation

Medical Disclaimer

This clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.

Advertisement
📖 Click any word to see its definition instantly! ×